Mayo Clinic and Cancer Genetics Inc. today launched OncoSpire Genomics, a joint venture with the singular goal of improving cancer care by discovering and commercializing diagnostic tests that leverage next-generation sequencing. OncoSpire will focus on mutually identified projects in the Biomarker Discovery Program within Mayo’s Center for Individualized Medicine. Mayo Medical Laboratories and Mayo Clinic’s Department of Laboratory Medicine and Pathology will work with Mayo’s Center for Individualized Medicine to help bring discoveries from the joint venture to patients at Mayo Clinic and elsewhere.
In this video, Mayo Clinic gastroenterologist and celiac disease expert Joseph Murray, M.D., discusses a recent article published in Alimentary Pharmacology & Therapeutics that examined the effectiveness of larazotide acetate as an alternative treatment for celiac disease.
In mid-March, the Centers for Disease Control and Prevention and the World Health Organization announced the presence of a novel coronavirus in the Arabian Peninsula and the United Kingdom. In this video, Matthew Binnicker, Ph.D., laboratory director of the Mayo Clinic Virology Laboratory, outlines key things health care providers should know about this coronavirus and proper testing protocol.